FSFI endpoint comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-06-27. Numbers and descriptions here follow the published literature rather than marketing material.
Bremelanotide is a synthetic cyclic heptapeptide developed under the research code PT-141. The code reflects its position in an internal compound series rather than a chemical classification, and the name bremelanotide was later adopted for regulatory filings. Structurally it belongs to the melanocortin peptide family and shares a core sequence motif with alpha-melanocyte-stimulating hormone. The compound is supplied as an acetate salt in aqueous solution for injection. In reference literature it is indexed under both the code and the generic name, a dual listing that can complicate database searches.
Early work on melanocortin analogs in the 1980s and 1990s produced peptides intended to influence pigmentation and appetite. One of these, melanotan II, was observed to affect sexual desire as an incidental finding in self-administration reports. Researchers then pursued analogs with altered receptor selectivity and improved handling characteristics, and PT-141 emerged from that program in the late 1990s. The development path moved from dermatology and metabolism toward a central nervous system application, a shift that shaped both trial designs and the eventual label.
Regulatory review of bremelanotide concluded in 2019 with approval in the United States for a defined indication in premenopausal women. The reviewed formulation is a single-use prefilled autoinjector given subcutaneously, and its label carries cardiovascular monitoring language tied to blood pressure changes recorded during trials. Availability outside the approving jurisdiction varies, and in several countries the compound remains unapproved or is handled as a prescription-only item. Compounded and research-grade material also circulates, and it differs from the reviewed product in purity, characterization, and chain of custody.
Bremelanotide functions as an agonist at several melanocortin receptor subtypes, with the strongest functional activity reported at the MC4 subtype. MC4 receptors sit in hypothalamic circuits that influence appetite, energy balance, and components of sexual behaviour. Rodents lacking functional MC4 receptors show altered mating behaviour, which supports a role for this pathway in desire. The precise sequence of events connecting receptor activation to reported human effects remains only partly characterised. Because the same receptor family governs pigmentation and inflammatory signalling, selectivity is a recurring theme in pharmacological discussion.
Clinical programmes in this area have relied mainly on randomised, double-blind, placebo-controlled designs in premenopausal women. Primary endpoints usually combine a validated questionnaire covering desire domains with counts of satisfying sexual events and a separate measure of distress. Reported outcomes show statistically significant but modest average improvement over placebo, with wide individual variation. Adverse events such as nausea, flushing, and headache occur frequently and can limit tolerability. Whether short-term trial gains translate into lasting change for most users is an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H68N14O10 | Cyclic heptapeptide core |
| Molecular weight | 1025.2 g/mol | Calculated for the free base |
| CAS registry number | 189691-06-3 | Free base; the acetate salt has a separate entry |
| Solubility class | Water-soluble | Freely soluble in aqueous media near neutral pH |
| Typical storage | 2 to 8 °C | Protect from light; avoid repeated freeze-thaw cycles |
Bremelanotide is a cyclic heptapeptide that acts as an agonist at melanocortin receptors. It binds MC1R, MC3R, MC4R, and MC5R, with MC4R activation considered most relevant to sexual desire pathways in the central nervous system. The molecule is a synthetic analog of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation and energy regulation. Early research explored its use in tanning before attention shifted toward sexual dysfunction applications. Receptor binding affinity varies across these subtypes.
Activation of MC4R in the hypothalamus is thought to influence dopaminergic signaling, which in turn affects arousal and desire. This mechanism differs from that of phosphodiesterase type 5 inhibitors, which act primarily on vascular smooth muscle in the genital region. Because the pathway is central rather than peripheral, effects are not strictly dependent on local blood flow. The precise downstream cascade linking receptor binding to behavioral outcomes remains an area of ongoing investigation.
Routine characterisation of bremelanotide relies on reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nm, where the peptide backbone absorbs. Mass spectrometry, typically in tandem mode with electrospray ionisation, confirms identity and supports quantification in biological matrices. Additional checks include amino acid analysis, peptide mapping after enzymatic digestion, and confirmation of the lactam bridge, since incomplete cyclisation produces a mass-shifted by-product. Purity values above 95 percent are common in reference-grade material, though reports vary in how strictly related substances are resolved from the parent peak.
The lyophilised solid is relatively stable when kept dry, protected from light and held at reduced temperature, commonly minus 20 degrees Celsius or lower for long-term storage. In solution the peptide is more vulnerable: tryptophan oxidation, hydrolysis of the lactam bridge and aggregation all become relevant over time, and the rate depends on pH, buffer composition and concentration. Repeated freeze-thaw cycles are generally avoided because they promote aggregation. Aqueous working solutions are typically prepared fresh or split into single-use aliquots to limit degradation before analysis.
Compared with the related compound melanotan II, PT-141 shows markedly weaker activation of receptors tied to pigmentation. This difference stems from subtle structural variations that alter affinity distribution across receptor subtypes. Investigators propose that such selectivity produces a different side effect profile in specific applications. However, downstream consequences of prolonged receptor activation remain uncertain in the literature. Published studies do not fully agree on the duration of signaling pathway activity and the mechanisms of desensitization.
From a pharmacokinetic standpoint, the peptide is usually delivered by injection because oral bioavailability is very low; proteases in the digestive tract degrade it rapidly. After subcutaneous administration, plasma concentrations reach a peak within roughly one hour. Its elimination half-life is relatively short, with most reports placing it in the range of a few hours. Nasal formulations have also been examined, though absorption varies widely between individuals. Metabolism proceeds mainly through peptidase cleavage, and the resulting products are excreted by the kidneys.
=== Outside mainland China === PRC Customs said exports of dairy products and eggs in 2007 were valued at US$359 million, a year-on-year increase of 90 per cent. Since the news of the melamine contamination began to circulate, at least 25 countries stopped importing Chinese dairy products. A number of countries had imposed blanket bans on Chinese milk products or its derivatives—among which were Bangladesh, Bhutan, Brunei, Burundi, Cameroon, Chile, Colombia, Dominican Republic, Gabon, India, Côte d'Ivoire, Maldives, Mali, Mexico, Nepal, Papua New Guinea, Paraguay, South Korea, Suriname, Tanzania, Togo, and the United Arab Emirates —joining Indonesia, Taiwan, Japan, Singapore and Malaysia which had also imposed specific bans on Chinese dairy products which tested positive for melamine.
Solvent assisted inlet ionization (SAII) is similar to matrix-assisted inlet ionization however the matrix is a solvent such as water, acetonitrile and methanol. This ionization technique is highly sensitive to small molecules, peptides and proteins. The analyte is dissolved in the solvent and can either be introduced to the heated inlet tube by a capillary column or directly injected into the inlet tube with a syringe or by pipetting. The capillary column is made of fused silica particles with one end submerged in the sample solvent and the other in the end of the heated inlet tube. The solvent flows through the capillary column without the use of a pump due to the pressure difference between ambient pressure and the vacuum. The temperature can vary in the inlet tube from 50 °C to 450 °C, with the lower temperature being used if the results obtained from a higher temperature are of good resolution. Solvent assisted inlet ionization can be coupled not only to liquid chromatography (LC) but also to nano LC.
The proposed plan would reduce commuter bus services and lines, delay the state's transition to electric buses, and cancel plans to expand the Brunswick Line. He later announced a one-year infusion of $150 million to the state's transportation fund, with most of the added funding being used to restore highway user revenue funding, to ease the effects of the cuts. Although the legislature included provisions to raise fees on vehicle registration for electric vehicles and heavier cars to prevent drastic cuts to the state's transportation projects, the Moore administration again proposed $1.3 billion in cuts to Maryland's transportation budget in September 2024, which would delay various infrastructure projects around the state, including the widening of the American Legion Memorial Bridge and the state's transition to electric buses. The proposed cuts would have also put the Maryland Transit Administration at risk of losing a federal grant that would have allowed it to replace the Baltimore LightRail's fleet of trains; however, this was avoided after Moore proposed about $420 million in vehicle-related fee increases in his fiscal year 2026 budget. In September 2025, the Moore administration proposed a $300 million funding increase for transportation projects in Maryland. In October 2024, Moore said he supported the widening of Interstate 81 in Maryland.
Sources: en.wikipedia.org
Alcoholism or its medical diagnosis alcohol use disorder refers to alcohol addiction, alcohol dependence, dipsomania, and/or alcohol abuse. It is a major problem and many health problems as well as death can result from excessive alcohol use. Alcohol dependence is linked to a lifespan that is reduced by about 12 years relative to the average person. In 2004, it was estimated that 4% of deaths worldwide were attributable to alcohol use. Deaths from alcohol are split about evenly between acute causes (e.g., overdose, accidents) and chronic conditions. The leading chronic alcohol-related condition associated with death is alcoholic liver disease. Alcohol dependence is also associated with cognitive impairment and organic brain damage. Some researchers have found that even one alcoholic drink a day increases an individual's risk of health problems by 0.4%. Two or more consecutive alcohol-free days a week have been recommended to improve health and break dependence.
=== December === 1 December – A Bangladeshi court convicts MP and former minister Tulip Siddiq of corruption charges and sentences her in her absence to two years in custody. Siddiq describes the sentence as "deeply unfair". Richard Hughes resigns as chair of the Office for Budget Responsibility as an inquiry is launched into how details of the November 2025 United Kingdom budget were published 40 minutes before Chancellor Rachel Reeves delivered the statement to Parliament. Former Conservative MPs Jonathan Gullis, Chris Green and Lia Nici defect to Reform UK. Belfast City Council votes in favour of flying the Palestinian flag above City Hall. 2 December – The High Court rejects an emergency legal application by Traditional Unionist Voice to have the Palestinian flag taken down from Belfast City Hall. 3 December – German President Frank-Walter Steinmeier and his wife Elke Büdenbender are welcomed by King Charles III and Queen Camilla on a state visit to the UK, the first to be made by a German leader for 27 years. Markus Campbell-Savours is suspended from the Parliamentary Labour Party for rebelling against the family farm tax. Reform UK launches an investigation into the online activity of Ian Cooper, the leader of Staffordshire County Council, following allegations he posted racist comments online. 5 December – It is announced that Chancellor Rachel Reeves will not face an investigation by ethics adviser Sir Laurie Magnus over whether or not her pre-budget interventions broke the ministerial code.
=== Sleep apnea === Sleep apnea is a condition characterized by repeated interruptions in breathing during sleep, significantly affecting the flow of blood through the brain's blood vessels. These interruptions cause intermittent hypoxia, leading to vascular changes such as the constriction of cerebral blood vessels, thereby impacting overall brain blood flow. Sleep apnea can also result in reduced blood flow in the ciliary artery area, contributing to the development of NAION through various mechanisms. The results of a retrospective study investigating high altitude (7,000-9,000 feet) as a potential risk factor for NAION suggested that high-altitude-associated NAION might be linked to undiagnosed obstructive sleep apnea. The study concluded that NAION could occur under high-altitude conditions, often in younger individuals with obstructive sleep apnea and "disc-at-risk". Each apnea episode typically causes temporary increases in blood pressure and heart rate, leading to fluctuations that can result in irregular blood flow to the brain. This may cause long-term changes in the structure and function of cerebral blood vessels. The brain's mechanism for maintaining constant blood flow despite changes in systemic blood pressure, known as cerebral autoregulation, can be impaired by sleep apnea. This impairment results in periods of both reduced and excessive cerebral blood flow. Repeated airway obstruction during sleep leads to intermittent hypoxia, causing oxidative stress and damaging endothelial cells of blood vessels, including those supplying the optic nerve head.
Sources: en.wikipedia.org
PT-141 was the internal development code assigned to bremelanotide during preclinical research. Reference sources sometimes index the peptide under the code rather than the generic name. The two terms describe the same molecule.
They are related but distinct cyclic peptides. Melanotan II is an earlier and less selective melanocortin analog. Bremelanotide was developed later with a narrower receptor profile and a defined clinical application.
The reviewed product is given by subcutaneous injection using a single-use autoinjector. Administration occurs under prescription supervision. The device delivers one fixed amount per use rather than a measured or adjustable quantity.
The approved formulation is given by subcutaneous injection and is used on an as-needed basis rather than on a fixed daily schedule. An intranasal version was studied earlier but did not reach the same stage of development. Route of delivery strongly affects how quickly the peptide appears in circulation.